Skip to main content
SpringerLink
Log in

Transcatheter Therapy for Aortic Stenosis: A Review of the Literature

  • Chapter
  • First Online:
Percutaneous Treatment of Left Side Cardiac Valves

  • 1044 Accesses

Abstract

“Even if the development of transcatheter aortic valve implantation (TAVI) can be considered a success story today, it is nothing short of a miracle, as the project appeared particularly challenging - not to say totally unrealistic - at its origin in the early 1990s.” These are the words that Cribier used to define the history of TAVI as a genuine odyssey, which, however, over the years has been increasingly recognized as a revolutionary technique in aortic valve stenosis (AS).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Letac B, Cribier A, Koning R, Bellefleur JP. Results of percutaneous transluminal valvuloplasty in 218 adults with valvular aortic stenosis. Am J Cardiol. 1988;62(9):598–605.

    Article  CAS  PubMed  Google Scholar 

  2. Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry. Circulation. 1991;84(6):2383–97.

    Google Scholar 

  3. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J. 1992;13:704–8.

    Article  CAS  PubMed  Google Scholar 

  4. Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356(9239):1403–5.

    Article  CAS  PubMed  Google Scholar 

  5. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006–8.

    Article  PubMed  Google Scholar 

  6. Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol. 2004;43:698–70.

    Article  PubMed  Google Scholar 

  7. Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol. 2006;47:1214–23.

    Article  PubMed  Google Scholar 

  8. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation. 2006;113:842–50.

    Article  PubMed  Google Scholar 

  9. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding corevalve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50:69–76.

    Article  PubMed  Google Scholar 

  10. Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2008;29(11):1463–70.

    Article  PubMed  Google Scholar 

  11. Eltchaninoff H, Prat A, Gilard M, et al. On behalf of the FRANCE Registry Investigators. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J. 2011;32:191–7.

    Article  PubMed  Google Scholar 

  12. Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic valve implantation in high-risk patients. N Engl J Med. 2012;366(18):1705–15.

    Article  CAS  PubMed  Google Scholar 

  13. Zahn R, Gerckens U, Grube E, et al. On behalf of the German Transcatheter Aortic Valve Interventions—Registry Investigators. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J. 2001;32:198–204.

    Article  Google Scholar 

  14. Walther T, Hamm CW, Schuler G, et al., on behalf of the GARY Executive Board. Perioperative results and complications in 15,964 transcatheter aortic valve replacements. Prospective data from the GARY Registry. J Am Coll Cardiol. 2015;65(20):2173–80.

    Google Scholar 

  15. Tamburino C, Capodanno D, Mulè M, et al. Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prothesis. J Invasive Cardiol. 2009;21:93–8.

    PubMed  Google Scholar 

  16. Ussia GP, Barbanti M, Petronio AS, et al., on behalf of the CoreValve Italian Registry Investigators. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. Eur Heart J. 2012;33(8):969–76.

    Google Scholar 

  17. Barbanti M, Petronio AS, Ettori F, et al. 5-Year outcomes after transcatheter aortic valve implantation with CoreValve prosthesis. JACC Cardiovasc Interv. 2015;8(8):1084–91.

    Article  PubMed  Google Scholar 

  18. Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol. 2011;58:2130–8.

    Article  PubMed  Google Scholar 

  19. Duncan A, Ludman P, Banya W, et al. Long-term outcomes after transcatheter aortic valve replacement in high-risk patients with severe aortic stenosis. The U.K. Transcatheter Aortic Valve Implantation Registry. JACC Cardiovasc Interv. 2015:645–53.

    Google Scholar 

  20. Ludman PF, Moat N, de Belder MA, et al. Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, 2007 to 2012. Circulation. 2015;131(13):1181–90.

    Article  PubMed  Google Scholar 

  21. Mack MJ, Brennan JM, Brindis R, et al., STS/ACC TVT Registry. Outcomes following transcatheter aortic valve replacement in the United States. JAMA. 2013;310(19):2069–77.

    Google Scholar 

  22. Holmes DR Jr, Brennan JM, Rumsfeld JS, et al. STS/ACC TVT Registry. Clinical outcomes at 1 year following transcatheter aortic valve replacement. JAMA. 2015;313(10):1019–28.

    Google Scholar 

  23. Holmes DR Jr, Nishimura RA, Grover FL, et al. STS/ACC TVT Registry. Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry. J Am Coll Cardiol. 2015 Dec 29;66(25):2813–23. .

    Google Scholar 

  24. Rode’s-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010;55:1080–90.

    Article  Google Scholar 

  25. Rodés-Cabau J, Webb JG, Cheung A, et al. Long-term outcomes after transcatheter aortic valve implantation; insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol. 2012;60:1864–75.

    Article  PubMed  Google Scholar 

  26. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010;122:62–9.

    Article  PubMed  Google Scholar 

  27. Thomas M, Schymik G, Walther T, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2011;124:425–33.

    Article  PubMed  Google Scholar 

  28. Schymik G, Lefèvre T, Bartorelli AL, et al. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry. JACC Cardiovasc Interv. 2015;8(5):657–69.

    Article  PubMed  Google Scholar 

  29. SOURCE 3 post-approval registry - early outcomes in 1,946 TAVI patients with a third-generation balloon expandable transcatheter heart valve. Presented by O Wendler at EuroPCR 2016.

    Google Scholar 

  30. Linke A, Wenaweser P, Gerckens U, et al. Treatment of aortic stenosis with a self-expanding transcatheter valve: the International Multi-centre ADVANCE Study. Eur Heart J. 2014;35:2672–84.

    Article  PubMed  Google Scholar 

  31. Popma JJ, Adams DH, Reardon MJ, et al. Transcatheter Aortic Valve Replacement Using a Self-Expanding Bioprosthesis in Patients with Severe Aortic Stenosis at Extreme Risk for Surgery. J Am Coll Cardiol. 2014, 1972;63(19):–81.

    Google Scholar 

  32. Piazza N, van Gameren M, Jüni P, et al. A comparison of patient characteristics and 30-day mortality outcomes after transcatheter aortic valve implantation and surgical aortic valve replacement for the treatment of aortic stenosis: a two-centre study. EuroIntervention. 2009;5:580–8.

    Article  PubMed  Google Scholar 

  33. Tamburino C, Barbanti M, Capodanno D, et al. Comparison of complications and outcomes to one year of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis. Am J Cardiol. 2012;109(10):1487–93.

    Article  PubMed  Google Scholar 

  34. Piazza N, Kalesan B, van Mieghem N, et al. A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients. JACC Cardiovasc Interv. 6(5, 2013):443–51.

    Google Scholar 

  35. Wenaweser P, Stortecky S, Schwander S, et al. Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation. Eur Heart J. 2013;34:1894–905.

    Article  CAS  PubMed  Google Scholar 

  36. Tamburino C, Barbanti M, D’Errigo P, et al. 1-Year outcomes after transfemoral transcatheter or surgical aortic valve replacement. Results from the Italian OBSERVANT Study. J Am Coll Cardiol. 2015;66(7):804–12.

    Article  PubMed  Google Scholar 

  37. Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387(10034):2218–25.

    Article  PubMed  Google Scholar 

  38. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.

    Article  CAS  PubMed  Google Scholar 

  39. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.

    Article  CAS  PubMed  Google Scholar 

  40. Makkar RR, Fontana GP, Jilaihawi H, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366(18):1696–704.

    Article  CAS  PubMed  Google Scholar 

  41. Kapadia SR, Leon MB, Makkar RR, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2485–91.

    Article  PubMed  Google Scholar 

  42. Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic valve replacement. N Engl J Med. 2012;366:1686–95.

    Article  CAS  PubMed  Google Scholar 

  43. Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385:2477–84.

    Article  PubMed  Google Scholar 

  44. Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–20.

    Article  CAS  PubMed  Google Scholar 

  45. Nielsen HH, Klaaborg KE, Nissen H, et al. A prospective, randomised trial of transapical transcatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis: the STACCATO trial. EuroIntervention. 2012;8:383–9.

    Article  PubMed  Google Scholar 

  46. Thyregod HG, Steinbruchel DA, Ihlemann N, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol. 2015;65:2184–94.

    Article  PubMed  Google Scholar 

  47. Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790–8.

    Article  CAS  PubMed  Google Scholar 

  48. Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement. The CHOICE Randomized Clinical Trial. JAMA. 2014;311(15):1503–14.

    Article  PubMed  Google Scholar 

  49. Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376:1321–31.

    Article  PubMed  Google Scholar 

  50. Gargiulo G, Sannino A, Capodanno D, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement: a systematic review and meta-analysis. Ann Intern Med. 2016;165(5):334–44.

    Article  PubMed  Google Scholar 

  51. Manoharan G, Walton AS, Brecker SJ, et al. Treatment of symptomatic severe aortic stenosis with a novel resheathable supra-annular self-expanding transcatheter aortic valve system. JACC Cardiovasc Interv. 2015;8(10):1359–67.

    Article  PubMed  Google Scholar 

  52. Kempfert J, Holzhey D, Hofmann S, et al. First registry results from the newly approved ACURATE TA™ TAVI system. Eur J Cardiothorac Surg. 2015;48(1):137–41.

    Article  PubMed  Google Scholar 

  53. Meredith IT, Worthley SG, Whitbourn RJ, et al. Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study. EuroIntervention. 2014;9(11):1264–70.

    Article  PubMed  Google Scholar 

  54. Meredith IT, Walters DL, Dumonteil N, et al. 1-year outcomes with the fully repositionable and retrievable lotus transcatheter aortic replacement valve in 120 high-risk surgical patients with severe aortic stenosis: results of the REPRISE II Study. JACC Cardiovasc Interv. 2016;9(4):376–84.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ferrarotto Hospital, University of Catania, Via Citelli 6, 95124, Catania, Italy

    Davide Capodanno

  2. Division of Cardiology – Ferrarotto Hospital, University of Catania, Catania, Italy

    Simona Gulino

Authors
  1. Davide Capodanno
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Simona Gulino
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Davide Capodanno .

Editor information

Editors and Affiliations

  1. Ferrarotto Hospital, University of Catania, Catania, Italy

    Corrado Tamburino

  2. Ferrarotto Hospital, University of Catania, Catania, Italy

    Marco Barbanti

  3. Ferrarotto Hospital, University of Catania, Catania, Italy

    Davide Capodanno

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Capodanno, D., Gulino, S. (2018). Transcatheter Therapy for Aortic Stenosis: A Review of the Literature. In: Tamburino, C., Barbanti, M., Capodanno, D. (eds) Percutaneous Treatment of Left Side Cardiac Valves. Springer, Cham. https://doi.org/10.1007/978-3-319-59620-4_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-59620-4_28

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-59619-8

  • Online ISBN: 978-3-319-59620-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation